Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Prince

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Oral Oncology|April 26, 2017
Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinomaAndrew C Birkeland, Susan K Foltin, Nicole L Michmerhuizen, et al.
Head & Neck|January 17, 2012
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR statusMatthew E Spector, K Kelly Gallagher, Emily Light, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Oral Oncology|August 18, 2016
Predictors of severe long-term toxicity after re-irradiation for head and neck cancerJae Y Lee, Krithika Suresh, Rebecca Nguyen, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 13, 2020
Prioritizing Diversity in Otolaryngology-Head and Neck Surgery: Starting a ConversationCarl M Truesdale, Reginald F Baugh, Michael J Brenner, et al.
Oral Oncology|January 25, 2018
Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinomaRebecca Hoesli, Andrew C Birkeland, Andrew J Rosko, et al.
Oncotarget|July 1, 2021
Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinomaCatherine T Haring, Chandan Bhambhani, Collin Brummel, et al.
Head & Neck|August 22, 2012
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerShamir P Chandarana, Julia S Lee, Eric J P Chanowski, et al.
Head & Neck|September 17, 2009
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Oral Oncology|April 26, 2017
Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinomaAndrew C Birkeland, Susan K Foltin, Nicole L Michmerhuizen, et al.
Head & Neck|January 17, 2012
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR statusMatthew E Spector, K Kelly Gallagher, Emily Light, et al.
JAMA Otolaryngology-- Head & Neck Surgery|February 20, 2016
Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma TreatmentMatthew E Spector, Steven B Chinn, Emily Bellile, et al.
Oral Oncology|August 18, 2016
Predictors of severe long-term toxicity after re-irradiation for head and neck cancerJae Y Lee, Krithika Suresh, Rebecca Nguyen, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 13, 2020
Prioritizing Diversity in Otolaryngology-Head and Neck Surgery: Starting a ConversationCarl M Truesdale, Reginald F Baugh, Michael J Brenner, et al.
Oral Oncology|January 25, 2018
Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinomaRebecca Hoesli, Andrew C Birkeland, Andrew J Rosko, et al.
Oncotarget|July 1, 2021
Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinomaCatherine T Haring, Chandan Bhambhani, Collin Brummel, et al.
Head & Neck|August 22, 2012
Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerShamir P Chandarana, Julia S Lee, Eric J P Chanowski, et al.
Head & Neck|September 17, 2009
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansJessica H Maxwell, Bhavna Kumar, Felix Y Feng, et al.
Oral Oncology|February 26, 2014
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerJeffrey M Vainshtein, Matthew E Spector, Jonathan B McHugh, et al.
Pageof 13